Author archive: scd-admin

Elucigene Diagnostics, developer and manufacturer of leading prenatal and human genetics diagnostics have partnered with Southern Cross Diagnostics to service their growing customer base in Australia and New Zealand. Elucigene Diagnostics’ range of high-quality and innovative test kit for rapid aneuploidy analysis, reproductive health, and single gene disorders are CE-IVD marked and TGA approved. The…

In May 2016 DiaSorin purchased the Focus Diagnostics products business including molecular diagnostics, ELISA and IFA. DiaSorin has acquired all of the assets to develop, manufacture and distribute these products and will continue to manufacture the Focus Diagnostics range of products from the company’s facility in Cypress, California, USA, under the new name of DiaSorin…

SCD is pleased to announce the exclusivity distribution of Energium products in Australia. Specialising in robotics and automation, Energium tackles the problems that exist in the phlebotomy process. Its HENs product portfolio speeds up collection process and reduce errors made significantly. In a recent paper published in the Annals of medicine, over 60% of mistakes…

It’s going to be an epidemic flu season in Australia according to The Australian Medical Association (AMA). The Australian flu flu trend follows very closely to that of the Northern Hemisphere, which peaks in January and February. And health authorities in the US are already seeing a peak of 6.1% people presenting with influenza like…

See you at the MMM

Southern Cross Diagnostics is please to announce its continuing support through its MMM sponsorship. To be held in March, the Molecular Microbiology Meeting (MMM) provides research scientists, laboratory staff and clinicians to share the latest issues and developments in the field of molecular microbiology. For more information and registration – head to the MMM website….

Bordetella now IVD

In partnership with Focus Diagnostics – one of the biggest reference labs in USA – Southern Cross Diagnostics is please to announce that the Simplexa Bordetella pertussis and parapertussis molecular diagnostic kit is now registered as an IVD. Pertussis is one of the most frequent and potentially fatal childhood respiratory illnesses in Australia. As an…

Menu